Accidents Hémorragiques Graves Lors D'un Traitement Par Héparine De Bas Poids Moléculaire. À Propos De Deux Observations
La Revue de médecine interne(1997)
摘要
Two cases of fatal bleeding in patients treated with low molecular weight heparin for deep vein thrombosis are reported. Risk factors for bleeding were: severe underlying disease (cancer in one case, morbid obesity and cardiac failure in the other), age over 80 years and worsening of renal insufficiency in both cases, recent surgical procedure in one case. Anti-Xa activity was beyond the therapeutic range at the time of bleeding in both cases. The usefulness of biologically monitoring the treatment of deep vein thrombosis with low molecular weight heparin is discussed.
更多查看译文
关键词
low molecular weight heparin,haemorrhage,anti-Xa activity,risk factors for bleeding,venous thrombosis
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要